Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Short-Term Debt

GlaxoSmithKline CR`s Short-Term Debt reached 0 CZK mil in 2017. This is the same as in the previous year.

$1.99

Buy Short-Term Debt data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             0 0 0 39.8 71.8    
Bayer Czech Republic CZK mil ... ... ...                 0 0 90.1 28.5 151    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 362 240 320 0 0    
Merck Czech Republic CZK mil ... ...                   141 123 145 21.8 0    
Novartis Czech Republic CZK mil                       205 55.2 0 96.0 0    
Pfizer Czech Republic CZK mil ... ...                   856 0 0 0 0    
Roche Czech Republic CZK mil ... ... ...                 0 151 285 541 660   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               1,165 1,410 883 471 404    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 0 0 0 0    
Walmark CZK mil ... ... ...                 195 31.0 62.4 194 1,413